Scarica l'app Stockscreener
0.51
2.62%
0.013
Dopo l'orario di chiusura:
.53
0.02
+3.92%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TTOO Giù?
Forum
Previsione
Frazionamento azionario
T 2 Biosystems Inc Borsa (TTOO) Ultime notizie
T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey
T2 Biosystems: Q3 Earnings Snapshot - mySA
Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Analysis of ARMISTICE CAPITAL, LLC's Recent Trade in T2 Biosyste - GuruFocus.com
T2 Biosystems Reports Increased Losses and Cash Crunch - TipRanks
T2 Biosystems Inc (TTOO) Quarterly 10-Q Report - Quartz
T2 Biosystems Announces Third Quarter 2024 Financial Results - The Manila Times
T2 Biosystems Reports 34% Revenue Growth, Signs Cardinal Health Distribution Deal | TTOO Stock News - StockTitan
T2 Biosystems stock plunges to 52-week low of $0.55 By Investing.com - Investing.com Canada
500: Something went wrong - Investing.com
T2 Biosystems Faces Potential Delisting from Nasdaq due to Market Value - Defense World
T2 Biosystems (TTOO) Scheduled to Post Earnings on Thursday - Defense World
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 - GlobeNewswire
T2 Biosystems Forges Sales Deal With Cardinal Health for Sepsis Test - MPO-mag
T2 Biosystems stock plunges to 52-week low of $0.81 - Investing.com
T2 Biosystems stock plunges to 52-week low at $1.08 By Investing.com - Investing.com Australia
T2 Biosystems stock plunges to 52-week low at $1.08 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.37 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.37 By Investing.com - Investing.com UK
T2 Biosystems reports progress in product pipeline By Investing.com - Investing.com South Africa
T2 Biosystems reports progress in product pipeline - Investing.com India
Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships By Investing.com - Investing.com South Africa
Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.53 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.53 By Investing.com - Investing.com UK
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems - Yahoo Finance
T2 Biosystems to Host Business Update Call on October 10, 2024 - ForexTV.com
T2 Biosystems and Prxcision announce sepsis solution collaboration By Investing.com - Investing.com South Africa
T2 Biosystems and Prxcision announce sepsis solution collaboration - Investing.com India
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform - The Manila Times
T2 Biosystems, Inc. and Prxcision, Inc. Announce - GlobeNewswire
Market Watch: T2 Biosystems Inc (TTOO)’s Noteworthy Drop, Closing at 1.63 - The Dwinnex
T2 Biosystems reports 35% revenue growth in Q3 - Investing.com
T2 Biosystems reports 35% revenue growth in Q3 By Investing.com - Investing.com South Africa
T2 Biosystems secures exclusive deal with Cardinal Health - Investing.com
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results - The Manila Times
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens - The Manila Times
T2 Biosystems secures exclusive deal with Cardinal Health By Investing.com - Investing.com Australia
T2 Biosystems Announces Exclusive U.S. Agreement with - GlobeNewswire
5.04%
3.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):